• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, November 17, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Glutamate Receptor Antagonism Disrupts Reward Processing in Mouse Models

by
November 16, 2026
in Health
Reading Time: 2 mins read
0
Glutamate Receptor Antagonism Disrupts Reward Processing in Mouse Models

Glutamate Receptor Antagonism Disrupts Reward Processing in Mouse Models

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A recent study published in the journal Translational Psychiatry has identified a critical role for metabotropic glutamate 2/3 receptors (mGluR2/3) in the orchestration of reward-related behaviors. Researchers investigating the neurobiological foundations of motivation found that systemic administration of the selective mGluR2/3 antagonist LY341495 significantly impairs the behavioral response to natural rewards in mice, affecting both ingestive and social domains. By utilizing a combination of head-fixed temporal conditioning tasks and freely moving behavioral paradigms, the research team demonstrated that these receptors are fundamental to the reward processing circuitry, functioning independently of general motor or orofacial movement impairments.

In the head-fixed temporal conditioning experiments, the researchers observed that mice developed anticipatory licking behaviors and pupil dilation in anticipation of receiving a 10% sucrose solution, confirming successful temporal expectation. When systemic doses of the antagonist LY341495 were administered, the mice exhibited a dose-dependent reduction in both anticipatory and consummatory licking responses. Normalization analyses further suggested that LY341495 reduced the overall expression of licking behavior while largely preserving its temporal organization.

LY341495 also induced pupil dilation and attenuated reward-proximity–related pupillary modulation. The study utilized control tasks to ensure that the observed behaviors were not confounded by motor side effects. Assessment of locomotor activity in an open-field task showed no significant decline in mobility following administration of the compound, and the production of ultrasonic vocalizations (USVs) during social courtship interactions remained stable.

These observations indicate that the disruption in behavior following mGluR2/3 antagonism is not the result of non-specific motor dysfunction or impairment in orofacial coordination.

The study further expanded the scope of this effect by evaluating social interaction, finding that LY341495 administration significantly decreased social preference in mice. This indicates that the effects of mGluR2/3 antagonism extend beyond ingestive behavior to social reward-related processes. LY341495 also dose-dependently reduced food intake.

These results have significant implications for the understanding of neuropsychiatric disorders characterized by diminished motivational drive and anhedonia, such as depression.

In summary, the administration of the mGluR2/3 antagonist LY341495 creates a distinct profile of behavioral impairment characterized by reduced anticipation and consumption of rewards, alongside diminished social preference. Because these effects occur in the absence of general motor dysfunction, they provide strong evidence that mGluR2/3 signaling is directly involved in the motivation to pursue rewards across varied domains.

Subject of Research: Neurobiology of reward and motivation

Article Title: Systemic administration of the mGluR2/3 antagonist LY341495 disrupts reward-related behaviors across ingestive and social domains in mice

Article References: Inoue, H., Yamamoto, M., Tamai, Y., Matsushima, S., Yamada, K., Hayashi, K., & Toda, K. (2026). Systemic administration of the mGluR2/3 antagonist LY341495 disrupts reward-related behaviors across ingestive and social domains in mice. Translational Psychiatry. https://doi.org/10.1038/s41398-026-04446-z

Image Credits: AI Generated

DOI: 10.1038/s41398-026-04446-z

Keywords: mGluR2/3 receptors, LY341495, glutamate signaling, reward processing, motivation, anhedonia, translational psychiatry, mouse models, behavioral neurobiology, sucrose consumption, social preference, pupillometry, neuropharmacology, ingestive behavior, neuropsychiatry

News Source: Glenn Wilkins. (November 16, 2026). Glutamate Receptor Antagonism Disrupts Reward Processing in Mouse Models. Scienmag.

Tags: anhedoniabehavioral neurobiologyGlutamate signalingingestive behaviorLY341495mGluR2/3 receptorsmotivationmouse modelsNeuropharmacologyneuropsychiatrypupillometryReward Processingsocial preferencesucrose consumptionTranslational Psychiatry
Share12Tweet7Share2ShareShareShare1

Related Posts

Four Key Clinical Factors Associated With Heart Injury in Gastrointestinal Bleeding

Four Key Clinical Factors Associated With Heart Injury in Gastrointestinal Bleeding

November 17, 2026
Specialized EBI3-High Dendritic Cell Subset Identified in Rheumatoid Arthritis Synovial Fluid

Specialized EBI3-High Dendritic Cell Subset Identified in Rheumatoid Arthritis Synovial Fluid

November 17, 2026

Early Tildrakizumab Treatment Predicts Complete Psoriasis Clearance in Five-Year Italian Study

November 17, 2026

Obsessive-Compulsive Disorder Patients Show Altered Emotional Processing and Oculomotor Control Patterns

November 17, 2026

POPULAR NEWS

  • Four Key Clinical Factors Associated With Heart Injury in Gastrointestinal Bleeding

    Four Key Clinical Factors Associated With Heart Injury in Gastrointestinal Bleeding

    29 shares
    Share 12 Tweet 7
  • Nanjing Hospital Study Finds 19.2 Percent HPV Positivity Among 39,335 Women

    29 shares
    Share 12 Tweet 7
  • Specialized EBI3-High Dendritic Cell Subset Identified in Rheumatoid Arthritis Synovial Fluid

    29 shares
    Share 12 Tweet 7
  • Early Tildrakizumab Treatment Predicts Complete Psoriasis Clearance in Five-Year Italian Study

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Four Key Clinical Factors Associated With Heart Injury in Gastrointestinal Bleeding

Nanjing Hospital Study Finds 19.2 Percent HPV Positivity Among 39,335 Women

Specialized EBI3-High Dendritic Cell Subset Identified in Rheumatoid Arthritis Synovial Fluid

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.